Skip to main content
OpenTrials
Completed

NCT Number: NCT00549172

Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear

Degenerative meniscal tears are the most common etiology for knee pain, swelling and loss of function. Partial arthroscopic meniscectomy is the most common orthopaedic procedure to treat meniscal tears. Improvements have been reported both after arthroscopy and with conservative treatment, however no direct comparison exist. Accordingly, the aim of this study is to assess the efficacy of arthroscopic partial meniscectomy for the treatment of degenerative tear of medial meniscus of the knee using a double-blind, placebo controlled, randomised trial.

Completed

Looking for future studies?

Notify Me

Key information

Age range

35 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Helsinki Central Hospital, Helsinki, Finland

Loading trial locations.

About this study

Middle-aged men and women with degenerative meniscal tears constitute a large group of patients presenting with knee pain, sometimes accompanied with swelling and loss of function. Many meniscal tears occur without a trauma in physically active individuals as well as in older people and could be a part of early osteoarthritis. Partial arthroscopic meniscectomy is the most common orthopaedic procedure and is used to treat patients with meniscal tears. Many patients report improvement after arthroscopy referring especially to reduced knee pain, better knee function and improved quality of life. However, similar results have also been obtained with conservative treatment (physical therapy) of patients with degenerative meniscal tears. Accordingly, the aim of this study is to assess the efficacy of arthroscopic partial meniscectomy for the treatment of degenerative tear of medial meniscus of the knee using a double-blind, placebo controlled, randomised trial. The outcome of arthroscopic partial meniscectomy (vs. sham surgery) is assessed using the Lysholm knee score and pain at rest and activity (VAS) at 2, 6 and 12 months after the operation. In addition, the functional outcome is assessed using the WOMET knee score (a disease-specific quality of life -knee score development on the assessment of meniscal pathology), the general quality of life score (15-D), and cost-effectiveness analysis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: 35 to 65 years of age.
  • A pain located on the medial joint line of the knee that has persistent at least for 3 months.
  • Pain that can be provoked by palpation or compression of the joint line or a positive McMurray sign.
  • Tear of the medial meniscus on MRI.
  • Degenerative rupture of the medial meniscus confirmed at arthroscopy.

Exclusion criteria

  • Acute, trauma-induced onset of symptoms.
  • Locking or painful snapping of the knee joint.
  • A surgical operation performed on the affected knee.
  • Osteoarthritis of the medial compartment of the knee (determined by clinical criteria of the ACR).
  • Osteoarthritis on knee radiographs (Kellgren-Lawrence > 1).
  • Acute (within the previous year) fractures of the knee.
  • Decreased range of motion of the knee.
  • Instability of the knee.
  • MRI assessment showing a tumor or any other complaint requiring surgical or other means of treatment.
  • Arthroscopic assessment showing anything other than a degenerative tear of the medial meniscus requiring surgical intervention.

Treatment and study plan

Operative (partial arthroscopy)

Procedure

Partial arthroscopic resection of degenerative rupture of the medial meniscus

Conservative (diagnostic arthroscopy)

Procedure

Diagnostic arthroscopy

Primary outcomes

  1. The Lysholm Knee Score

    Time frame: One year

    The Lysholm knee score is based on an eight-item questionnaire designed to evaluate knee function and symptoms in activities of daily living. Scores range from 0 to 100; higher scores indicate less severe symptoms.

  2. Pain After Exercise (VAS)

    Time frame: One year

    Knee pain after exercise (during the preceding week) was assessed on a rating scale of 0 to 10, with 0 denoting no pain and 10 denoting extreme pain.

  3. WOMET (Western Ontario Meniscal Tear -Disease Specific Quality of Life -Assessment Tool)

    Time frame: One year

    The Western Ontario Meniscal Evaluation Tool (WOMET) contains 16 items addressing three domains: 9 items addressing physical symptoms; 4 items addressing disabilities with regard to sports, recreation, work, and lifestyle; and 3 items addressing emotions. The score indicates the percentage of a normal score; therefore, 100 is the best possible score, and 0 is the worst possible score.

Secondary outcomes

  1. 15-D (General Quality of Life -Assessment Tool)

    Time frame: One year

    The 15D instrument is a generic health-related quality-of-life instrument comprising 15 dimensions. The maximum 15D score is 1 (full health), and the minimum score is 0 (death).

  2. Pain at Rest (VAS)

    Time frame: One year

    Knee pain at rest (during the preceding week) was assessed on a rating scale of 0 to 10, with 0 denoting no pain and 10 denoting extreme pain.

  3. Cost Effectiveness

    Time frame: 1 and 2 years

    Cost effectiveness data comparing arthroscopic partial meniscectomy and diagnostic arthroscopy. Costs are based on healthcare utilisation and sickness absence.

Sponsors and collaborators

Lead sponsor

Tampere University

Other

Collaborators

  • Central Finland Hospital District
  • Helsinki University Central Hospital
  • Kuopio University Hospital
  • Turku University Hospital

Registry information

Official study title

Efficacy of Arthroscopic Partial Resection for the Degenerative Tear of the Medial Meniscus of a Knee

Important dates

Study start
2007
Primary completion
2013
Study completion
2013
First posted
Oct 25, 2007
Registry last updated
Jan 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.